554 related articles for article (PubMed ID: 16164710)
21. A histopathological approach: when papulopustular lesions should be in the diagnostic criteria of Behçet's disease?
Kalkan G; Karadag AS; Astarci HM; Akbay G; Ustun H; Eksioglu M
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1056-60. PubMed ID: 19453803
[TBL] [Abstract][Full Text] [Related]
22. Expression of Fas, Bcl-2 and p53 molecules in glomerulonephritis and their correlations with clinical and laboratory findings.
Uğuz A; Gönlüşen G; Ergin M; Tuncer I
Nephrology (Carlton); 2005 Jun; 10(3):311-6. PubMed ID: 15958048
[TBL] [Abstract][Full Text] [Related]
23. Expression of cytokeratins, adhesion and activation molecules in oral ulcers of Behçet's disease.
Kose O; Stewart J; Waseem A; Lalli A; Fortune F
Clin Exp Dermatol; 2008 Jan; 33(1):62-9. PubMed ID: 17983454
[TBL] [Abstract][Full Text] [Related]
24. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
[TBL] [Abstract][Full Text] [Related]
25. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis and related proteins during parturition in prostaglandin F receptor-deficient mice.
Mu J; Kanzaki T; Si X; Tomimatsu T; Fukuda H; Fujii E; Hosono T; Murata Y; Sugimoto Y; Ichikawa A
Biochem Biophys Res Commun; 2002 Apr; 292(3):675-81. PubMed ID: 11922619
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of bcl-2 in lymphocytes of psoriatic skin.
Yildiz L; Bariş S; Senturk N; Kandemir B
J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):538-40. PubMed ID: 12941088
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptor levels in the sebaceous glands of papulopustular lesions from patients with Behçet's disease and acne vulgaris: a controlled study.
Durusoy C; Alpsoy E; Elpek O; Karpuzoglu G
Adv Clin Path; 2002 Apr; 6(2):87-93. PubMed ID: 19753730
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis in chronic adult periodontitis analyzed by in situ DNA breaks, electron microscopy, and immunohistochemistry.
Gamonal J; Bascones A; Acevedo A; Blanco E; Silva A
J Periodontol; 2001 Apr; 72(4):517-25. PubMed ID: 11338305
[TBL] [Abstract][Full Text] [Related]
30. Can specific vessel-based papulopustular lesions of Behçet's disease be differentiated from nonspecific follicular-based lesions clinically?
Boyvat A; Heper AO; Koçyiğit P; Erekul S; Gürgey E
Int J Dermatol; 2006 Jul; 45(7):814-8. PubMed ID: 16863517
[TBL] [Abstract][Full Text] [Related]
31. Lack of association between leptin G2548A gene polymorphism and Behçet's disease.
Aydin F; Kara N; Senturk N; Gunes S; Canturk MT; Bagci H; Bek Y; Turanli AY
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):68-71. PubMed ID: 17207170
[TBL] [Abstract][Full Text] [Related]
32. Chromosome and sister chromatid exchange studies in Behcet's patients.
Oztas S; Gullulu G; Tatar A; Astam N; Akyol I; Karakuzu A; Aktas A; Odabas AR
J Dermatol; 2006 Jun; 33(6):406-10. PubMed ID: 16700831
[TBL] [Abstract][Full Text] [Related]
33. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease--a multicenter study. The Behcet's Disease Research Committee of Japan.
J Rheumatol; 1989 Apr; 16(4):506-11. PubMed ID: 2664172
[TBL] [Abstract][Full Text] [Related]
34. Conjunctival ulcers in Behçet's disease.
Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
[TBL] [Abstract][Full Text] [Related]
35. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions.
Hussein MR; Al-Badaiwy ZH; Guirguis MN
J Cutan Pathol; 2004 Nov; 31(10):643-51. PubMed ID: 15491323
[TBL] [Abstract][Full Text] [Related]
36. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma.
Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G
Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116
[TBL] [Abstract][Full Text] [Related]
38. Genotoxicity assessment using comet assay in Behcet's disease patients.
Bilgici B; Bedir A; Sentürk N; Alvur M; Aydin F; Turanli AY
Mutat Res; 2005 Oct; 578(1-2):170-4. PubMed ID: 16019038
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma.
Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A
Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity of S49.1 cells to anti-CD95 (Fas/Apo-1)-induced apoptosis: effects of CD95, Bcl-2 or Bcl-x transduction.
Broome HE; Dargan CM; Brunner T; Green DR
Cell Death Differ; 1998 Mar; 5(3):200-5. PubMed ID: 10200465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
